Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumabl…
Medical - Devices
US, Menlo Park [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer Group
Configuration
Company | Price d* | Change d* | Volume, Avg. k, d* | Market Cap. d* | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding d* | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Medical Devices Average | - - | - - | - - | 23,453.02 | 1,129.62 | 115.02 | 2,780.73 | 27.60 | 0.00 | 8.2044 | 0.76 | 0.5025 | -0.8639 | -0.01 | -0.02 | 4.0627 | - - | ||
Maximum | - - | - - | - - | 201,023.00 | 9,964.00 | 1,225.00 | 38,011.00 | 627.00 | 0.01 | 191.2553 | 13.46 | 1.0000 | 0.6285 | 0.06 | 0.08 | 21.0359 | - - | ||
Minimum | - - | - - | - - | 2.00 | 0.00 | -252.00 | -2,869.00 | -138.00 | 0.00 | -252.6195 | -2.66 | -2.8076 | -24.2050 | -0.17 | -0.51 | 0.0000 | - - | ||
Pacific Biosciences of California, Inc. PACB | 1.59 | -0.26 -14.02% | 22,652 vs. 8,922 | 436.00 | 38.00 | -78.00 | -79.00 | -1,917.00 | -0.2900 | -3.1465 | 0.0000 | 0.1141 | -2.0144 | -0.1205 | -0.0468 | 8.1224 | 273.00 | ||
Intellia Therapeutics, Inc. NTLA | 13.97 | -1.15 -7.61% | 3,609 vs. 1,965 | 1,422.00 | 28.00 | -107.00 | -123.00 | -1,765.00 | -1.1200 | -6.0491 | 0.0000 | 0.9132 | -3.7130 | -0.1037 | -0.0853 | 8.4537 | 101.00 | ||
CRISPR Therapeutics AG CRSP | 47.25 | 0.40 0.85% | 3,131 vs. 1,191 | 4,032.00 | 0.00 | -116.00 | 109.00 | -1,116.00 | -1.4300 | -11.9580 | 0.0000 | -101.7758 | -231.3313 | -0.0559 | -0.0478 | 17.7168 | 85.00 |
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.